Review
Published on 08 Jul 2021
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.684561
- 21,442 views
- 20 citations
Type at least 3 characters
2,059 articles
articles
Systematic Review
Published on 08 Jul 2021
Circulating miRNAs as Auxiliary Diagnostic Biomarkers for Multiple Myeloma: A Systematic Review, Meta-Analysis, and Recommendations
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.698197
- 4,213 views
- 14 citations
Review
Published on 07 Jul 2021
Opportunities and Challenges for Gut Microbiota in Acute Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.692951
- 7,528 views
- 18 citations
Original Research
Published on 07 Jul 2021
Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.668099
- 5,179 views
- 24 citations
Original Research
Published on 06 Jul 2021
HNRNPH1 Is a Novel Regulator Of Cellular Proliferation and Disease Progression in Chronic Myeloid Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.682859
- 7,286 views
- 28 citations
Original Research
Published on 06 Jul 2021
Long Non-Coding RNA LINC00152 Regulates Self-Renewal of Leukemia Stem Cells and Induces Chemo-Resistance in Acute Myeloid Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.694021
- 4,519 views
- 19 citations
Case Report
Published on 05 Jul 2021
Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.693670
- 7,637 views
- 21 citations
Case Report
Published on 02 Jul 2021
Successful Outcome of Programmed Death 1 Blockade Plus GemOx for Epstein-Barr Virus-Associated Primary Nodal T/NK Cell Lymphoma: A Case Report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.706865
- 3,565 views
- 5 citations
Review
Published on 01 Jul 2021
HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.685706
- 10,313 views
- 36 citations
Original Research
Published on 01 Jul 2021
Prognostic and Therapeutic Value of Apolipoprotein A and a New Risk Scoring System Based on Apolipoprotein A and Adenosine Deaminase in Chronic Lymphocytic Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.698572
- 3,592 views
- 5 citations
Systematic Review
Published on 01 Jul 2021
Efficacy and Safety of Ibrutinib in Central Nervous System Lymphoma: A PRISMA-Compliant Single-Arm Meta-Analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.707285
- 11,277 views
- 22 citations
Review
Published on 01 Jul 2021
Amino Acid Metabolic Vulnerabilities in Acute and Chronic Myeloid Leukemias
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.694526
- 7,608 views
- 14 citations
Original Research
Published on 30 Jun 2021
New-Onset Severe Cytopenia After CAR-T Cell Therapy: Analysis of 76 Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.702644
- 8,866 views
- 49 citations
Case Report
Published on 29 Jun 2021
Case Report: Very Late, Atypical Extra-Medullary Relapse in a Patient With Acute Promyelocytic Leukemia (APL) Rescued With a Transplant-Free Approach
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.699886
- 3,315 views
- 1 citation
Original Research
Published on 29 Jun 2021
Intratumor Heterogeneity of MIF Expression Correlates With Extramedullary Involvement of Multiple Myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.694331
- 7,200 views
- 12 citations
Case Report
Published on 25 Jun 2021
Secondary Hemophagocytic Lymphohistiocytosis With Epstein–Barr Virus-Associated Transformed Follicular Lymphoma: A Case Report and Literature Review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.681432
- 3,880 views
- 2 citations
Review
Published on 24 Jun 2021
Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.663961
- 5,868 views
- 13 citations
Original Research
Published on 24 Jun 2021
Lenalidomide and Rituximab Regimen Combined With Intravitreal Methotrexate Followed by Lenalidomide Maintenance for Primary Vitreoretinal Lymphoma: A Prospective Phase II Study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.701507
- 4,124 views
- 15 citations
Original Research
Published on 24 Jun 2021
Prospective Observational Study of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma: Microbiota Profiling and Cytokine Expression
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.704722
- 5,342 views
- 13 citations
Clinical Trial
Published on 18 Jun 2021
Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.687374
- 5,317 views
- 17 citations
Original Research
Published on 18 Jun 2021
Combined Inhibition of Akt and mTOR Is Effective Against Non-Hodgkin Lymphomas
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.670275
- 5,440 views
- 12 citations
Brief Research Report
Published on 18 Jun 2021
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.703254
- 2,992 views
- 2 citations
Original Research
Published on 15 Jun 2021
G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Mantle Cell Lymphoma Growth in Preclinical Models
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.668617
- 4,895 views
- 13 citations
Original Research
Published on 15 Jun 2021
Treatment Induced Cytotoxic T-Cell Modulation in Multiple Myeloma Patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.682658
- 3,560 views
- 4 citations